Drug manufacturers, under fire from consumer advocacy groups for opposing legislation to reduce prescription costs, announced Tuesday that they would spend about $30 million through June to develop and promote a program that would help poor Americans gain access to the medicines they need.
Throughout the country, hundreds of public and private programs already provide some assistance to consumers who can't afford their prescriptions. But finding out about the programs and accessing them can be a daunting bureaucratic task for doctors, let alone consumers.
